The debate over the U.S. Preventive Services Task Force's (USPSTF) final recommendation on PSA testing continued this week. Michael Barry, president of the Informed Medical Decisions Foundation and Mary McNaughton-Collins, medical director, each had an opportunity to speak on NPR radio programs about the USPSTF recommendation this week. They voiced their views on the recommendation -- both from the perspective of the Foundation and as practicing primary care physicians.
The recent New England Journal of Medicine paper titled “Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence” look at thirty-two years of cancer statistics in the U.S. and comes to the startling conclusion that roughly 1.3 million women have been overdiagnosed with breast cancer. In our newest “Foundation Perspectives” video, Dr. Mary McNaughton-Collins, medical director at the Informed Medical Decisions Foundation and a primary care doctor, gives us her take on the importance of this study. She provides a brief overview of the authors’ findings, explains why the overdiagnosis of breast cancer is harmful and provides her view on how these findings will affect how she engages women in a shared decision making conversation about screening mammograms.
Who should decide about screening for prostate cancer: expert panels of clinicians and methodologists, primary care clinicians, specialists, or fully informed patients themselves? The U.S. Preventive Services Task Force recently released a draft recommendation on screening for prostate cancer, designed for primary care physicians and health systems, and has opened if for public comment until November 8, 2011.